Several years ago, drug maker Gilead Science Inc. applied for a Chinese patent for the use of Remdesivir against coronaviruses. Remdesivir was originally intended to treat Ebola but was also shown to inhibit coronaviruses, such as SARS.
Recently, scientists at the government-run Wuhan Institute of Virology, along with a military laboratory, reportedly applied to patent the use of Remdesivir to treat the specific coronavirus, Covid-19, which is being blamed for the recent outbreak.
No decision has been made regarding the Gilead patent application. However, if approved, as a member of the WTO, the Chinese government may be able to use the TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement to obtain a compulsory licence for Remdesivir. If so, the Chinese government would decide, subject to any appeal, what payment Gilead would receive.
In considering the Wuhan Institute’s application, the Chinese patent office will likely have to consider issues of anticipation and obviousness.
For its part, Gilead is helping end the current crisis by working with health authorities. The company is reportedly providing Remdesivir for emergency use in clinical trials.
In vitro studies of Remdesivir and chloroquine have been published in Cell Research, stating that the mixture is effective for inhibiting Covid-19.
Author: Matthew Buck
Authors
Expertise
Insights
-
Intellectual Property
Bacardí Toasts to a Successful Appeal
There has been a new development in a long-standing trademark dispute between Bacardí and the Cuban government entity, Cubaexport, over the "Havana Club" name. Bacardí won its appeal at the US… -
Intellectual Property
Warhol: Landmark Copyright Case Settles
The Andy Warhol Foundation for the Visual Arts has reportedly agreed to settle a copyright infringement proceeding with Lynn Goldsmith over a photograph of Prince that Goldsmith claimed Andy Warhol… -
Intellectual Property
Boeing Lawsuit Blasts Off: Virgin Galactic Accused of Stealing Trade Secrets
Boeing and its subsidiary, Aurora Flight Sciences, are reportedly suing Virgin Galactic, a space tourism start-up, for allegedly misappropriating trade secrets and failing to pay $25 million for work… -
Intellectual Property
All Posts Game, Set, Match: Sony PlayStation Victorious in Patent Infringement Lawsuit
In 2017, Genuine Enabling Technology (“GET”) filed a complaint against the Sony Corporation (“Sony”), which included a claim that Sony infringed one of its patents related to a method of communication… -
Intellectual Property
Goodmans Wins Leading IP Law Firm – IP Patents at the Lexology Awards: North America 2024
We are proud to share Goodmans has won Leading IP Law Firm - IP Patents at the Lexology Awards: North America 2024. These awards celebrate outstanding achievements and world class client… -
Intellectual Property
Protecting Heads and the Ideas Inside: Yamaha’s Augmented Reality Helmet
A Yamaha patent application has been published for a new design of an augmented reality (AR) motorcycle helmet. The design introduces transparent lenses, which aim to combine the power of the AR…